The Safety and Immunogenicity of Acellular Pertussis Vaccine in Bone Marrow Transplant Recipients

NCT00336115 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Pertussis

Interventions

BIOLOGICAL: Tetanus and Diphtheria Toxoids Adsorbed Combined with Acellular Pertussis (Adacel)

Sponsor

Queen Elizabeth II Health Sciences Centre